美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Tvardi Therapeutics Inc

17.04

-1.2095-6.63%

盤後：16.15-0.8891-5.22%16:54 EDT

成交量：3.82萬

成交額：65.28萬

市值：1.59億

市盈率：-1.10

高：19.80

開：17.96

低：15.13

收：18.25

資料載入中...

總覽公司新聞公告

BUZZ-Cara Therapeutics 宣佈反向拆股後股價上漲

Cara Therapeutics, Inc.盤中異動大幅上漲6.49%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TVRD/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TVRD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVRD\",,,,,undefined,":{"symbol":"TVRD","market":"US","secType":"STK","nameCN":"Tvardi Therapeutics Inc","latestPrice":17.0391,"timestamp":1744920000000,"preClose":18.2486,"halted":0,"volume":38248,"hourTrading":{"tag":"盘后","latestPrice":16.15,"preClose":17.0391,"latestTime":"16:54 EDT","volume":316,"amount":5106.8,"timestamp":1744923247847},"delay":0,"floatShares":3316400,"shares":9355542,"eps":-15.531682,"marketStatus":"休市中","change":-1.2095,"latestTime":"04-17 16:00:00 EDT","open":17.96,"high":19.8,"low":15.1301,"amount":652804.509896,"amplitude":0.255905,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-15.531682,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"listingDate":1391144400000,"exchange":"NASDAQ","adjPreClose":18.2486,"preHourTrading":{"tag":"盘前","latestPrice":15.5,"preClose":18.06,"latestTime":"09:24 EDT","volume":267,"amount":4501.361543999999,"timestamp":1744896279023},"postHourTrading":{"tag":"盘后","latestPrice":16.15,"preClose":17.0391,"latestTime":"16:54 EDT","volume":316,"amount":5106.8,"timestamp":1744923247847},"volumeRatio":1.1665172183900896},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVRD\",,,,,undefined,":{"symbol":"TVRD","floatShares":3316400,"roa":"--","roe":"--","lyrEps":-15.531682,"volumeRatio":1.1665172183900896,"shares":9355542,"dividePrice":0,"high":19.8,"amplitude":0.255905,"preClose":18.2486,"low":15.1301,"week52Low":8.1252,"pbRate":"--","week52High":31.32,"institutionHeld":0,"latestPrice":17.0391,"eps":-15.531682,"divideRate":0,"volume":38248,"delay":0,"ttmEps":-15.531682,"open":17.96,"prevYearClose":18.36,"prevWeekClose":14.7,"prevMonthClose":15.21,"prevQuarterClose":15.21,"fiveDayClose":14.595,"twentyDayClose":15.45,"sixtyDayClose":14.34},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TVRD\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527118418","title":"BUZZ-Cara Therapeutics 宣佈反向拆股後股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2527118418","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527118418?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 00:36","pubTimestamp":1744648564,"startTime":"0","endTime":"0","summary":"BUZZ-Cara Therapeutics 宣布反向拆股后股价上涨4月14日 -  ** 生物制药公司 Cara Therapeutics CARA.O 股价上涨 14.5% 至 5.61 美元  ** Cara 表示 ，董事会已批准从 4 月 15 日起进行 1 对 3 的反向股票分割 ** 卡拉公司于 12 月与私人控股的 Tvardi Therapeutics 公司达成合并协议 ** 预计合并完成后，股票分割将以新名称 \"Tvardi Therapeutics Inc \"进行，股票代码为 \"TVRD\"。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nL4T3QS1BI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARA","TVRD","BK4007"],"gpt_icon":0},{"id":"2526848274","title":"Cara Therapeutics, Inc.盤中異動 大幅上漲6.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526848274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526848274?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 00:23","pubTimestamp":1744129439,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日00时23分，Cara Therapeutics, Inc.股票出现波动，股价大幅拉升6.49%。Cara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Cara Therapeutics, Inc.公司简介：Cara Therapeutics Inc 是一家处于开发阶段的生物技术公司，致力于开发新型疗法来治疗与炎症、疼痛和瘙痒相关的人类疾病。Cara 的 CR845 旨在治疗急性疼痛和瘙痒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409002400aa2c62b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409002400aa2c62b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","TVRD","CARA"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TVRD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-04-16","symbol":"TVRD","defaultRemindTime":1744810200000,"type":"split","dateTimestamp":1744776000000,"forFactor":3,"toFactor":1,"ratio":3},{"market":"US","date":"2025-03-11","symbol":"TVRD","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-12-31","symbol":"TVRD","defaultRemindTime":1735655400000,"type":"split","dateTimestamp":1735621200000,"forFactor":12,"toFactor":1,"ratio":12},{"market":"US","date":"2024-11-14","symbol":"TVRD","fiscalQuarterEnding":"2024/09","expectedEps":-0.25,"name":null,"time":"盤後","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.15},{"market":"US","date":"2024-08-14","symbol":"TVRD","fiscalQuarterEnding":"2024/06","expectedEps":-0.29,"name":null,"time":"盤後","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":-0.37}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TVRD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TVRD\",market:\"US\",delay:false,,,undefined,":{}}}